Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine | 09/24 08:30 | prnewswire.com |
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference | 09/18 08:30 | prnewswire.com |
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium | 09/03 08:30 | prnewswire.com |
Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference | 08/26 08:30 | prnewswire.com |
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting | 07/29 08:45 | prnewswire.com |
Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy | 07/23 08:15 | prnewswire.com |
Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology | 07/17 08:00 | prnewswire.com |
Anixa Biosciences Announces $5 Million Share Repurchase Program | 07/15 08:30 | prnewswire.com |
Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial | 06/24 08:45 | prnewswire.com |
7 Penny Biotech Stocks to Triple Your Investment | 05/28 06:10 | investorplace.com |